Stockscreener 앱 받기
4.84
1.47%
0.07
시장 영업 전:
4.81
-0.03
-0.62%
Recursion Pharmaceuticals Inc 주식(RXRX)의 최신 뉴스
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 4,149,346 Shares of Recursion Pharmaceuticals, Inc. $RXRX - MarketBeat
Short Squeeze: What are analysts price targets for Recursion Pharmaceuticals IncJuly 2025 Levels & Free Safe Entry Trade Signal Reports - خودرو بانک
Aug PostEarnings: Is Recursion Pharmaceuticals Inc forming a double bottom2025 Price Momentum & AI Powered Trade Plan Recommendations - خودرو بانک
Recursion Pharmaceuticals (RXRX) Drops on 3rd Day as Company Execs Dispose of Shares - MSN
Recursion Pharmaceuticals (NASDAQ:RXRX) Given Buy Rating at Needham & Company LLC - MarketBeat
Goldman Sachs Group Inc. Sells 481,645 Shares of Recursion Pharmaceuticals, Inc. $RXRX - MarketBeat
Needham, known as a 'biotech stock picker,' is betting on this leader in 'AI + drug discovery,' forecasting a 68% surge in its stock price. - 富途牛牛
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 8.7%Should You Buy? - MarketBeat
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know - sharewise.com
Recursion Pharmaceuticals (RXRX): How Recent Drug Development Moves and Investor Outreach Shape Valuation - Sahm
Needham Retains Buy Rating on Recursion Pharmaceuticals, Maintains PT at $8 - Yahoo Finance
Recursion Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:RXRX) - MarketBeat
Aug Setups: Is Elastic NV stock overvalued or fairly pricedTrade Volume Summary & Weekly High Potential Alerts - خودرو بانک
Recursion Pharmaceuticals, Inc. $RXRX Shares Purchased by Advisors Asset Management Inc. - MarketBeat
Is Recursion Pharmaceuticals (NASDAQ:RXRX) Using Debt In A Risky Way? - 富途牛牛
Recursion Pharmaceuticals Stock: An Exponential Climb? - timothysykes.com
Will Recursion Pharmaceuticals Rise or Fall? - StocksToTrade
RXRX’s Market Strategy: Analyzing Recent Developments - timothysykes.com
Recursion Pharmaceuticals Stock (RXRX) Opinions on AI-Driven Pipeline Updates - Quiver Quantitative
Oversold Conditions For Recursion Pharmaceuticals (RXRX) - Nasdaq
Needham Maintains Recursion Pharmaceuticals(RXRX.US) With Buy Rating, Maintains Target Price $8 - 富途牛牛
Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia - MSN
Russell Investments Group Ltd. Has $206,000 Stock Position in Recursion Pharmaceuticals, Inc. $RXRX - MarketBeat
Is Recursion Pharmaceuticals Inc. forming a breakout patternJuly 2025 Big Picture & AI Forecast for Swing Trade Picks - beatles.ru
Ranking Recursion Pharmaceuticals Inc. among high performing stocks via toolsSwing Trade & Daily Price Action Insights - Newser
Tools to assess Recursion Pharmaceuticals Inc.’s risk profileJuly 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Published on: 2025-09-08 04:20:29 - Newser
Applying Wyckoff theory to Recursion Pharmaceuticals Inc. stockQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Using Ichimoku Cloud for Recursion Pharmaceuticals Inc. technicalsEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Analyzing recovery setups for Recursion Pharmaceuticals Inc. investors2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser
Real time alert setup for Recursion Pharmaceuticals Inc. performanceBond Market & Free Community Consensus Stock Picks - Newser
Detecting support and resistance levels for Recursion Pharmaceuticals Inc.CEO Change & High Win Rate Trade Tips - Newser
Multi asset correlation models including Recursion Pharmaceuticals Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser
How to read the order book for Recursion Pharmaceuticals Inc.Market Weekly Review & Verified Swing Trading Watchlist - Newser
Will Recursion Pharmaceuticals Inc. stock recover after recent drop2025 Technical Patterns & Reliable Price Action Trade Plans - Newser
Historical volatility pattern of Recursion Pharmaceuticals Inc. visualizedGold Moves & Weekly Chart Analysis and Guides - Newser
Volatility clustering patterns for Recursion Pharmaceuticals IncJuly 2025 Breakouts & High Yield Equity Trading Tips - Newser
Chart based exit strategy for Recursion Pharmaceuticals Inc.2025 Institutional Moves & Real-Time Volume Analysis - Newser
Recursion Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Can Recursion Pharmaceuticals Inc. rally from current levels2025 Price Momentum & AI Forecasted Entry and Exit Points - Newser
How to escape a deep drawdown in Recursion Pharmaceuticals Inc.Portfolio Return Report & Free Expert Approved Momentum Trade Ideas - Newser
S P Trends: Will Recursion Pharmaceuticals Inc. outperform tech stocksRecession Risk & Technical Entry and Exit Alerts - خودرو بانک
What’s the recovery path for long term holders of Recursion Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Strategies - Newser
Will Recursion Pharmaceuticals Inc. see short term momentumIPO Watch & Real-Time Chart Pattern Alerts - Newser
Will Recursion Pharmaceuticals Inc. benefit from current market trends2025 Risk Factors & High Accuracy Swing Trade Signals - خودرو بانک
Is Recursion Pharmaceuticals Inc. in a long term uptrendInsider Buying & Safe Capital Growth Trade Ideas - خودرو بانک
Will Recursion Pharmaceuticals Inc. benefit from macro trendsMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Applying chart zones and confluence areas to Recursion Pharmaceuticals Inc.2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Forecasting Recursion Pharmaceuticals Inc. price range with options dataWeekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Is Recursion Pharmaceuticals Inc. a strong growth stockJuly 2025 Trade Ideas & Consistent Growth Equity Picks - خودرو بانک
0.77%
1.53%
자본화:
|
볼륨(24시간):